| Literature DB >> 31056680 |
Hanne Apers1, Christiana Nöstlinger1,2, Dominique Van Beckhoven3, Jessika Deblonde3, Ludwig Apers4, Katleen Verheyen5,6, Jasna Loos1.
Abstract
General practitioners (GPs) play a key role in reducing the hidden HIV-epidemic, but many diagnostic opportunities are missed in primary care. This study aimed at informing the development of an HIV-testing intervention for GPs in Flanders (Belgium) using formative research with a participatory approach. Through the active involvement of an advisory board and 16 group discussions with 122 Flemish GPs, GPs' current HIV-testing practices and perceived practical relevance of 2 distinct HIV-testing strategies (i.e. provider-initiated testing of key populations and indicator condition-based testing) were explored in terms of their relevance and feasibility in routine primary care. Self-reported HIV-testing practices revealed that most tests performed were patient-initiated, pretest counseling was rarely done, and post-test counseling was offered mainly for patients with an HIV-diagnosis. GPs reported multiple barriers to provider-initiated HIV-testing, i.e. personal discomfort, fear of offending their patient, limited knowledge of benefits of early HIV-diagnosis, misconceptions about HIV-risks, lack of guidelines and time. Difficulties to identify patient's sexual orientation or ethical concerns were mentioned as barriers for target group-based HIV testing. GPs assessed the current list of 64 indicator conditions as too difficult to integrate in routine care, deeming a reduced list of GP-relevant conditions as more feasible. Combined strategies (i.e. target group- and indicator-based testing) supported by official screening recommendations were perceived as successful strategies for provider-initiated HIV-testing in primary care. This formative research delivered qualitative evidence for the development of an HIV-testing intervention for primary care settings.Entities:
Keywords: HIV-testing; general practitioners; intervention; primary care; qualitative research
Year: 2020 PMID: 31056680 PMCID: PMC7250498 DOI: 10.1093/heapro/daz037
Source DB: PubMed Journal: Health Promot Int ISSN: 0957-4824 Impact factor: 2.483
Thematic analysis: data-driven codebook extract, translated from original language (Dutch)
|
| |
| Themes | Example |
| Subthemes | |
| Descriptive codes | |
| Provider-initiated HIV-testing | |
|
| |
|
| I would embed it in a more general consult, ‘a health check-up’ |
|
| When you are updating their medical file, asking after their medical history, stating that it is part of the anamnesis to run some preventive tests |
|
| |
|
| |
| Fear of damaging relation GP-patient | I think you should know your patient already longer, because if you suggest that in the first or second consult… I think that’s offensive |
|
| HIV is still associated with drugs and sex, multiple partners, or prostitution |
|
| With someone in a stable relationship that’s difficult; they might assume I suspect them or their partner to be cheating. |
|
| |
|
| When they have a simple cold, you can’t offer someone an HIV test. |
|
| We have to do already so many preventive tests, you shouldn’t increase the healthcare-costs more |
| Preference HIV-testing strategy | |
|
| I would prefer both strategies combined, because they are complementary and with this approach no-one is excluded. |
|
| |
|
| Those groups are easy to remember |
|
| It depends on the population and practice; if you screen target groups in Brussels, it will be more efficient |
|
| It is difficult to assess who is at risk, it’s easier to screen everyone |
|
| You could screen following a ‘scoring system’ with check points, as soon as a certain level is reached, an HIV- test is indicated |
|
| |
|
| |
| Assumptions and knowledge HIV-epidemic | |
|
| Here in our little town, we don't see HIV. In big cities like Antwerp it's a kind of trend |
|
| Do SAM who live in our country since long, also have a higher risk? |
|
| There are few people who have knowledge on HIV, its treatment, its symptoms, … For instance, I've never heard about this PEP-pill |
| Focus on patient’s consent for HIV-testing | |
|
| Ethically, we have to ask for consent. At least, that's how I've been thought, but well, I'm older of age ( |
|
| I think there shouldn't be a legal difference between testing for HIV or Hepatitis B |
|
| I ask the consent to test for all infectious diseases, not specifically for HIV |
Sociodemographic characteristics of all participants
| Women | Men | Total | ||||
|---|---|---|---|---|---|---|
|
| % |
| % |
| % | |
| Participants | 64 | 52.50% | 58 | 47.50% | 122 | 100% |
| Age (in years) | ||||||
| Median [range] | 44 [25–65] | 57 [25–73] | 51 [25–73] | |||
| Years of experience | ||||||
| Median [range] | 16.5 [0–38] | 30 [0–47] | 25 [0–47] | |||
| Type of practice | ||||||
| Solo practice, fee for service | 18 | 28.10% | 29 | 50.00% | 47 | 38.50% |
| Group practice, fee for service | 36 | 56.30% | 23 | 39.70% | 59 | 48.40% |
| Health center, capitation fee | 5 | 7.80% | 3 | 5.20% | 8 | 6.60% |
| Other | 5 | 7.80% | 3 | 5.20% | 8 | 6.60% |
| Number of patients/week | ||||||
| Median [range] | 85 [35–160] | 120 [20–300] | 100 [20–300] | |||
| Number of HIV patients in follow-up | ||||||
| Median [range] | 1 [0–20] | 1 [0–15] | 1 [0–20] | |||
| HIV tests/month | ||||||
| Median [range] | 4 [0–80] | 4 [0–80] | 4 [0–80] | |||
| Last HIV test performed | ||||||
| Provider-initiated | 17 | 30.40% | 12 | 20.70% | 29 | 25.40% |
| Patient-initiated | 39 | 69.60% | 46 | 79.30% | 85 | 74.60% |
Reported data, n=120.
Reported data, n =114.
Reported data, n=121.
Reported data, n=116.
Reported data, n=114.
Ten most diagnosed indicator conditions (left column) and ten most reported conditions indicative for offering an HIV test (right column) in GP practices
| Indicator conditions regularly diagnosed in GP practice | Indicator conditions which indicate GPs to test for HIV |
|---|---|
| 1. Sexually transmitted infections (STI) | 1. Sexually transmitted infection (STI) |
| 2. Herpes zoster | 2. Salmonella septicemia, recurrent |
| 3. Mononucleosis-like illness | 3. Unexplained leukocytopenia |
| 4. Seborrheic dermatitis/exanthema | 4. Hepatitis B or C |
| 5. Candidemia | 5. Unexplained lymphadenopathy |
| 6. Cervical dysplasia | 6. Malignant lymphoma |
| 7. Unexplained weight loss | 7. Peripheral neuropathy |
| 8. Peripheral neuropathy | 8. Mononucleosis-like illness |
| 9. Unexplained fever | 9. Coccidioidomycosis |
| 10. Unexplained chronic diarrhea | 10. Cytomegalovirus |